The validation data included 1408 patients with CRC, and the result also confirmed that SOX2 expression was significantly associated with worse OS (HR = 1.35, 95% CI: 1.11–1.65, P=0.004) (Figure 6(a)). This evidence concerns the gene SOX2 and colorectal carcinoma.